Clinical trial
Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant…
NCT00004033 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00004033 |
|---|---|
| Title | Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma |
| Official title | Phase II Clinical Study of a Liposome Entrapped Cisplatin Analog (L-NDDP) Administered Intrapleurally in Patients With Malignant Pleural Mesothelioma |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Mesothelioma |
| Intervention type | Drug, Procedure |
| Interventions | liposomal NDDP, therapeutic thoracoscopy |
| Enrollment | 30 |
| Start date | Sep 1, 1998 |
| Primary completion | May 1, 2001 |
| First posted | Apr 15, 2004 |
| Last update posted | Mar 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: